A new study points out that an aspirin a day keeps colon cancer away, meaning that this painkiller might lower the odds of developing colorectal cancer. The study was published in the journal Annals of Internal Medicine.
Researchers said people who took between 75 and 150 milligrams of aspirin for approximately five years experienced remarkable benefits and health boosts. To be more precise, the chances of men and women alike to develop colon cancer dropped by 27 percent.
However, cancer-protective aspects were expressly observed in subjects who took aspirin continuously for years. Researchers said that side effects might accumulate, nevertheless, in a period of 5 to 10 years.
On the other hand, the US Food and Drug Administration would warn the general public that side effects might include gastrointestinal bleeding. People ought to be cautious not to indulge in high-dosage of pain killers, as this might lead to a heart attack or stroke.
Health experts also said that, provided people took ibuprofen or other anti-inflammatory drugs for a period of 5 years, they had lesser chances for colorectal cancer to affect them by 30 to 45 percent. The non-steroidal anti-inflammatory medications bear the acronym NSAIDs.
The study’s co-author, Dr. John Baron, professor of medicine from the University of North Carolina, reported that the protective effects of common medication were remarkable.
However, risks may be at stake, as he explained that these drugs shouldn’t actually be taken to prevent cancer without them being prescribed by your doctor.
The research did not point out whether high doses of aspirin were linked to side effects, whereas protective aspects were not observed if people took lower doses of aspirin, on an irregular basis.
In the US, common pain relievers include Aleve, Advil and Motrin, the latter two being variants of ibuprofen. There’s also Celebrex, a drug which could be prescribed by a physician, whereas there’s another variant of Motrin – the high-strength one.
Moreover, health officials conducted the study by analyzing colon cancer databases from Denmark, including records of 10,000 Danes that were diagnosed with colon cancer in the period 1994-2011. Denmark-based patients were between 30 and 85 years of age.
100,000 healthy Danes were compared to the colon cancer sufferers, and the results pointed out that a low-dosage of NSAIDs could lead to protective patterns against colon cancer.
Furthermore, obese people are even more at risk of developing colorectal cancer, so it was assessed that a healthy weight should be reached and maintained.
Prof. Baron finally pointed out that their results were helpful to better understand the nature of several types of cancer.
Photo Credits archives.deccanchronicle.com